Desmoid tumour Treatment Outcome: A single institution experience
Biomedical and Clinical Research · 2022
DOI: 10.31579/2834-8486/003 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomedical and Clinical Research, 2022. Verfasst von Mohamed Hegazy.
Abstract (Originalsprache)
Desmoid tumour (DT) is a rare locally aggressive disease with tendency for local recurrence and the peak incidence age of 30-40 years. DT prognostic factors are still conflicting like surgical margin, disease location, age and gender. The various treatment options including surgery, radiotherapy and systemic agents are generally offered according to the disease presenting symptoms and progressiveness.
Zitieren
APA
Hegazy, M. (2022). Desmoid tumour Treatment Outcome: A single institution experience. Biomedical and Clinical Research. https://doi.org/10.31579/2834-8486/003
Vancouver
Hegazy M. Desmoid tumour Treatment Outcome: A single institution experience. Biomedical and Clinical Research. 2022. doi:10.31579/2834-8486/003
BibTeX
@article{Hegazy2022,
author = {Hegazy, Mohamed},
title = {Desmoid tumour Treatment Outcome: A single institution experience},
journal = {Biomedical and Clinical Research},
year = {2022},
doi = {10.31579/2834-8486/003}
}
EUVIMED